Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Researchers present long-term survival data on AVX-701 cancer vaccine

Nov. 17, 2015

Early clinical data for Macrogenics' MGA-271

Nov. 16, 2015

Daratumumab granted U.S. orphan status for diffuse large B-cell lymphoma

Nov. 16, 2015

Vadastuximab talirine from Seattle Genetics obtains FDA orphan drug designation

Nov. 13, 2015

Stanford University reports development of anti-CD99 MAbs

Nov. 12, 2015

New phase II trial investigates combination of CMB-305 and atezolizumab for soft tissue sarcoma

Nov. 12, 2015

Squamous NSCLC response rate improved when necitumumab added to paclitaxel-carboplatin

Nov. 10, 2015

Phase I findings for Bavarian Nordic's MVA-BN Brachyury cancer vaccine

Nov. 6, 2015

BriaCell receives FDA approval to begin phase I/IIa trial of BriaVax

Nov. 5, 2015

Innate initiates phase I study of IPH-4102 in CTCL

Nov. 5, 2015

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...